BGMSIndustrials · Building Products & Equipment

BGMS Stock Forecast: Bio Green Med Solution, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026

$0.87

+2.59% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 23 of 100 as at 12 Sept 2026 — in the weakest quartile.

Market cap

$5.8M

Ticker Nerd rank

23 / 100

Median analyst target

—

Analysts covering

—

Revenue$336K

Operating income−$418K

Net income−$405K

Free cash flow−$352K

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−5.2%

−3.1%

YTD

−41.1%

−86.3%

From 52W high

−86.3%

From 52W low

+45.3%

$0.60

$6.37

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

BGMS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Bio Green Med Solution, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026

23 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Growth

Accruals

Volatility

Momentum

Issuance

Revisions

Value

Quality

Size (95): Smaller than most of the companies we track.

Quality (8): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

BGMS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BGMS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BGMS appears on the weeks it earns a place.

Performance

BGMS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Bio Green Med Solution, Inc. returned −86.3% against +17.5% for the S&P 500, dividends included.

BGMS vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

BGMS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Bio Green Med Solution, Inc. (BGMS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 0.2×
Price / sales: 3.1×
Price / book: 0.8×
EV / EBITDA: −0.5×

Growth & margins

Revenue growth (YoY): −56.8%
Earnings growth (YoY): —
Gross margin: 23.5%
Operating margin: −124.4%
Net margin: −118.3%

Returns & dividend

Return on equity: 34.4%
Return on assets: −37.0%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Bio Green Med Solution, Inc. (BGMS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Bio Green Med Solution, Inc. has a market value of $5.8M and an enterprise value of $2.0M.
Revenue in the twelve months to 30 June 2026: $1.9M. The latest quarter shrank 56.8% year on year.
Net income over the same four quarters: −$2.2M, a −118.3% net margin.
Diluted earnings per share, trailing twelve months: $−3.64.
Free cash flow in the twelve months to 30 June 2026: −$1.1M.
Bio Green Med Solution, Inc. spent $61K on dividends in the twelve months to 30 June 2026.
Shares outstanding: 6.6M.
Trailing P/E: 0.2×.
Bio Green Med Solution, Inc. employs 0 people.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Sept 2026

Data provided by Twelve Data

Peers

BGMS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBuilding Products & Equipment

Company	Market cap	TKN rank
BGMSBio Green Med Solution, Inc.	$5.8M	23
ILAGIntelligent Living Application Group, Inc.	$6.1M	11
UUUUniversal Safety Products, Inc.	$16.3M	21
AEHLAntelope Enterprise Holdings Ltd.	$30.2M	3
KSCPKnightscope, Inc.	$32.0M	20
APTAlpha Pro Tech Ltd.	$53.8M	84
INVEIdentiv, Inc.	$61.8M	60

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Bio Green Med Solution, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest BGMS news & analysis

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

GlobeNewsWire · 12 Aug 2026neutral

Bio Green Med Solution, Inc. (NASDAQ: BGMS), a company focused primarily on fire safety protection and distribution activities, announced its second quarter financial results and provided a business update on August 12, 2026.

Why it matters — BGMS watchers would look to this report for the company's latest quarterly financial performance and management's assessment of its operations going forward.

FAQ

Frequently asked questions about BGMS stock

How does Ticker Nerd's model rank BGMS?

As at 12 Sept 2026, Bio Green Med Solution, Inc. ranks 23 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (95 of 100).

What is the BGMS stock forecast for 2030?

No analyst covering Bio Green Med Solution, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BGMS are extrapolating price history, which says nothing about the business.

How has BGMS stock performed over the past year?

Bio Green Med Solution, Inc. returned -86.3% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Bio Green Med Solution, Inc. do?

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.

What is the latest news on BGMS?

The most recent item we track (GlobeNewsWire, 12 Aug 2026): "BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE". Bio Green Med Solution, Inc. (NASDAQ: BGMS), a company focused primarily on fire safety protection and distribution activities, announced its second quarter financial results and provided a business update on August 12, 2026.

Company

About Bio Green Med Solution, Inc.

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

CEO Dr. Sing Ee Wong · Malaysia · https://bgmsglobal.com